Effects of valsartan, a type 1 angiotensin II receptor antagonist,on airway smooth muscle cells proliferation
Dan Chen
Abstract
Dan Chen
Abstract
Objective: To investigate the effect of type 1 angiotensin II receptor antagonist on airway smooth muscle cells prolifer-ation.Methods: Human airway smooth muscle cells(HASMCs) derived from human bronchus were cultured and stimulated with or with-out valsartan and angiotensin II in vitro.The proliferation rate of HASMCs was detected by MTT method.Cell cycle was detected by flow cytometry.Real-time PCR was explored to measure the mRNA expression level of transforming growth factor-β1(TGF-β1).Re-sults:(1)The proliferation rate of HASMCs was increased significantly in Ang II group.Compared with control group(P0.05),valsartan,a type 1 angiotensin II receptor antagonist,decreased the proliferation rate of cells stimulated by Ang II(P0.05).(2)Flow cytometry dis-closed that the Ang II increased significantly S phase of HASMCs(P0.05);valsartan decreased S phase of cells stimulated by Ang II(P0.05).(3)The expression of TGF-β1mRNA in the Ang II group were higher than that of control group(P0.05) and valsartan + Ang II group(P0.05).Conclusions: Type 1 angiotensin II receptor antagonist can inhibit the proliferation of HASMCs induced by AngII,prob-ably through the down-regulation of TGF-β1.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the effect of type 1 angiotensin II receptor antagonist on airway smooth muscle cells prolifer-ation.Methods: Human airway smooth muscle cells(HASMCs) derived from human bronchus were cultured and stimulated with or with-out valsartan and angiotensin II in vitro.The proliferation rate of HASMCs was detected by MTT method.Cell cycle was detected by flow cytometry.Real-time PCR was explored to measure the mRNA expression level of transforming growth factor-β1(TGF-β1).Re-sults:(1)The proliferation rate of HASMCs was increased significantly in Ang II group.Compared with control group(P0.05),valsartan,a type 1 angiotensin II receptor antagonist,decreased the proliferation rate of cells stimulated by Ang II(P0.05).(2)Flow cytometry dis-closed that the Ang II increased significantly S phase of HASMCs(P0.05);valsartan decreased S phase of cells stimulated by Ang II(P0.05).(3)The expression of TGF-β1mRNA in the Ang II group were higher than that of control group(P0.05) and valsartan + Ang II group(P0.05).Conclusions: Type 1 angiotensin II receptor antagonist can inhibit the proliferation of HASMCs induced by AngII,prob-ably through the down-regulation of TGF-β1.
Key concepts: Valsartan, Angiotensin II, Antagonist, Angiotensin II receptor type 1, Internal medicine, Endocrinology, Vascular smooth muscle, Flow cytometry